<p>紐約，2025 年 12 月 26 日（全球新聞稿）—— LifeMD, Inc.（納斯達克：LFMD），一家領先的虛擬初級醫療服務和藥房解決方案提供商，今天宣佈其董事會已授權向公司 8.875% 系列 A 累積永久優先股（納斯達克：LFMDP）的持有人支付現金股息，每股金額為 0.5546875 美元。</p>
<p>優先股息將於 2026 年 1 月 15 日支付給截至 2026 年 1 月 5 日營業結束時的登記持有人。</p>
<p><strong>關於 LifeMD, Inc.</strong></p>
<p>LifeMD®是領先的虛擬初級醫療提供商。LifeMD 提供遠程醫療、實驗室和藥房服務的訪問，以及針對 200 多種疾病的專業治療，涵蓋初級醫療、男性和女性健康、體重管理和激素治療。該公司利用垂直整合的專有數字護理平台、覆蓋 50 個州的附屬醫療集團、先進的附屬配藥藥房以及美國本土的患者護理中心，以增加高質量和可負擔護理的獲取。有關更多信息，請訪問 LifeMD.com。</p>
<p><strong>關於前瞻性聲明的警示説明</strong></p>
<p>本新聞稿包含根據 1933 年證券法第 27A 條、1934 年證券交易法第 21E 條及 1995 年美國私人證券訴訟改革法的安全港條款的前瞻性聲明。新聞稿中包含的前瞻性聲明可以通過使用諸如 “相信”、“期望”、“預期”、“項目”、“應該”、“計劃”、“將”、“可能”、“打算”、“估計”、“預測”、“繼續” 和 “潛在” 等詞語來識別，或在每種情況下，其否定形式或其他變體或參考未來時期的可比術語。前瞻性聲明的示例包括但不限於關於我們財務前景和指導、短期和長期業務表現和運營、未來收入和收益、監管發展、法律事件或結果、遵守複雜和不斷變化的法規的能力、市場條件和趨勢、新或擴展的產品和服務、增長策略、基本假設，以及上述任何因素對我們未來經營結果或財務狀況的影響的聲明。</p>
<p>前瞻性聲明不是歷史事實，也不是對未來表現的保證。這些聲明基於我們對未來計劃和策略、預測、預期和未預期事件和趨勢、經濟以及其他未來條件的當前期望、信念和假設，包括上述任何因素對我們未來業務的影響。由於前瞻性聲明涉及未來，因此它們受到固有風險、不確定性和難以預測的情況和假設變化的影響，其中一些超出我們的控制。因此，我們的實際結果、表現和財務狀況可能與前瞻性聲明中所指示的有重大差異。這些風險和不確定性包括但不限於我們向證券交易委員會提交的文件中識別的 “風險因素”，包括但不限於我們最近提交的 10-K 表格年度報告、10-Q 表格季度報告及其任何修正案。即使我們的實際結果、表現或財務狀況與此類文件中包含的前瞻性聲明一致，它們也可能不代表我們在後續期間的實際結果、表現或財務狀況。</p>
<p>本新聞稿中所作的任何前瞻性聲明均基於截至本聲明發布之日我們當前可獲得的信息。我們沒有義務更新或修訂任何前瞻性聲明，無論是由於新信息、未來事件還是其他原因，除非適用法律或法規要求。</p>
<p><strong>投資者聯繫</strong></p>
<p>首席財務官 Marc Benathen</p>
<p>marc@lifemd.com</p>
<p><strong>媒體聯繫</strong></p>
<p>首席營銷和產品官 Jessica Friedeman</p>
<p>press@lifemd.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd05UUXlPU00zTXpNeE5ERTNJekl3TVRrek5UYz0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd05UUXlPU00zTXpNeE5ERTNJekl3TVRrek5UYz0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NWFiYzAwOTMtYjg5Yy00ZDNiLTk1OGYtOWZlMWU2NjUwYzFiLTEwMzA5MzAtMjAyNS0xMi0yNi1lbg==/tiny/LifeMD-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NWFiYzAwOTMtYjg5Yy00ZDNiLTk1OGYtOWZlMWU2NjUwYzFiLTEwMzA5MzAtMjAyNS0xMi0yNi1lbg==/tiny/LifeMD-Inc-.png"/></p>

LFMD

<p>LifeMD, Inc. 宣佈將為其 8.875% A 系列累積永久優先股支付每股 $0.5546875 的季度現金股息，股息將於 2026 年 1 月 15 日支付給截至 2026 年 1 月 5 日的股東</p>

<p>NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.</p>
<div class="lb-trans"><p>紐約，2025 年 12 月 26 日（全球新聞稿）—— LifeMD, Inc.（納斯達克：LFMD），一家領先的虛擬初級醫療服務和藥房解決方案提供商，今天宣佈其董事會已授權向公司 8.875% 系列 A 累積永久優先股（納斯達克：LFMDP）的持有人支付現金股息，每股金額為 0.5546875 美元。</p>
</div><p>The preferred dividend will be paid on January 15, 2026, to holders of record at the close of business on January 5, 2026.</p>
<div class="lb-trans"><p>優先股息將於 2026 年 1 月 15 日支付給截至 2026 年 1 月 5 日營業結束時的登記持有人。</p>
</div><p><strong>About LifeMD, Inc.</strong></p>
<div class="lb-trans"><p><strong>關於 LifeMD, Inc.</strong></p>
</div><p>LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, spanning primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.</p>
<div class="lb-trans"><p>LifeMD®是領先的虛擬初級醫療提供商。LifeMD 提供遠程醫療、實驗室和藥房服務的訪問，以及針對 200 多種疾病的專業治療，涵蓋初級醫療、男性和女性健康、體重管理和激素治療。該公司利用垂直整合的專有數字護理平台、覆蓋 50 個州的附屬醫療集團、先進的附屬配藥藥房以及美國本土的患者護理中心，以增加高質量和可負擔護理的獲取。有關更多信息，請訪問 LifeMD.com。</p>
</div><p><strong>Cautionary Note Regarding Forward Looking Statements</strong></p>
<div class="lb-trans"><p><strong>關於前瞻性聲明的警示説明</strong></p>
</div><p>This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.</p>
<div class="lb-trans"><p>本新聞稿包含根據 1933 年證券法第 27A 條、1934 年證券交易法第 21E 條及 1995 年美國私人證券訴訟改革法的安全港條款的前瞻性聲明。新聞稿中包含的前瞻性聲明可以通過使用諸如 “相信”、“期望”、“預期”、“項目”、“應該”、“計劃”、“將”、“可能”、“打算”、“估計”、“預測”、“繼續” 和 “潛在” 等詞語來識別，或在每種情況下，其否定形式或其他變體或參考未來時期的可比術語。前瞻性聲明的示例包括但不限於關於我們財務前景和指導、短期和長期業務表現和運營、未來收入和收益、監管發展、法律事件或結果、遵守複雜和不斷變化的法規的能力、市場條件和趨勢、新或擴展的產品和服務、增長策略、基本假設，以及上述任何因素對我們未來經營結果或財務狀況的影響的聲明。</p>
</div><p>Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.</p>
<div class="lb-trans"><p>前瞻性聲明不是歷史事實，也不是對未來表現的保證。這些聲明基於我們對未來計劃和策略、預測、預期和未預期事件和趨勢、經濟以及其他未來條件的當前期望、信念和假設，包括上述任何因素對我們未來業務的影響。由於前瞻性聲明涉及未來，因此它們受到固有風險、不確定性和難以預測的情況和假設變化的影響，其中一些超出我們的控制。因此，我們的實際結果、表現和財務狀況可能與前瞻性聲明中所指示的有重大差異。這些風險和不確定性包括但不限於我們向證券交易委員會提交的文件中識別的 “風險因素”，包括但不限於我們最近提交的 10-K 表格年度報告、10-Q 表格季度報告及其任何修正案。即使我們的實際結果、表現或財務狀況與此類文件中包含的前瞻性聲明一致，它們也可能不代表我們在後續期間的實際結果、表現或財務狀況。</p>
</div><p>Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.</p>
<div class="lb-trans"><p>本新聞稿中所作的任何前瞻性聲明均基於截至本聲明發布之日我們當前可獲得的信息。我們沒有義務更新或修訂任何前瞻性聲明，無論是由於新信息、未來事件還是其他原因，除非適用法律或法規要求。</p>
</div><p><strong>Investor Contact</strong></p>
<div class="lb-trans"><p><strong>投資者聯繫</strong></p>
</div><p>Marc Benathen, Chief Financial Officer</p>
<div class="lb-trans"><p>首席財務官 Marc Benathen</p>
</div><p>marc@lifemd.com</p>
<div class="lb-trans"><p>marc@lifemd.com</p>
</div><p><strong>Media Contact</strong></p>
<div class="lb-trans"><p><strong>媒體聯繫</strong></p>
</div><p>Jessica Friedeman, Chief Marketing and Product Officer</p>
<div class="lb-trans"><p>首席營銷和產品官 Jessica Friedeman</p>
</div><p>press@lifemd.com</p>
<div class="lb-trans"><p>press@lifemd.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd05UUXlPU00zTXpNeE5ERTNJekl3TVRrek5UYz0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYwNTQyOSM3MzMxNDE3IzIwMTkzNTc="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NWFiYzAwOTMtYjg5Yy00ZDNiLTk1OGYtOWZlMWU2NjUwYzFiLTEwMzA5MzAtMjAyNS0xMi0yNi1lbg==/tiny/LifeMD-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/NWFiYzAwOTMtYjg5Yy00ZDNiLTk1OGYtOWZlMWU2NjUwYzFiLTEwMzA5MzAtMjAyNS0xMi0yNi1lbg==/tiny/LifeMD-Inc-.png"/></p>

LifeMD 宣佈對 A 系列累積永久優先股進行季度股息分配 | LFMD 股票新聞